18F-flouro-2-deoxyglucose positron emission tomography/computed tomography imaging of solitary prostatic and pulmonary tuberculosis mimicking metastatic prostate cancer

Kadihasanoglu, Mustafa; Yildiz, Tekin; Atahan, Safak; Ausmus, Andrew; Atahan, Ozcan
July 2015
Journal of Cancer Research & Therapeutics;Jul-Sep2015, Vol. 11 Issue 3, Special section p663
Academic Journal
case study
Genitourinary tuberculosis (TB) is a common type of extrathoracic TB and can be found in isolation or associated with pulmonary TB. It contributes to 10-14% of extrapulmonary TB. Prostate TB is rare and usually found incidentally following transurethral resection of the prostate for treatment of benign prostatic obstruction as an isolated lesion in immunocompetant patient. The authors report a case of prostatic and pulmonary TB in animmunocompetant patient investigating for the positive positron emission tomography in lung and prostate. To our knowledge, this is the first case reported in the literature presenting with simultaneous hypermetabolic lesions in the prostate and lung.


Related Articles

  • High-Intensity Focused Ultrasound (HIFU) Using Sonablate® Devices for the Treatment of Benign Prostatic Hyperplasia and Localized Prostate Cancer: 18-year experience. Toyoaki Uchida // AIP Conference Proceedings;2011, Vol. 1359 Issue 1, p9 

    From 1993 to 2010, we have treated 156 patients benign prostatic hyperplasia (BPH) and 1,052 patients localized prostate cancer high-intensity focused ultrasound (HIFU). Four different HIFU devices, SonablateR-200, SonablateR-500, SonablateR-500 version 4 and Sonablate® TCM, have been used...

  • Focal therapy for localized unifocal and multifocal prostate cancer: a prospective development study using real time MR guided Focused Ultrasound. Napoli, A.; Caliolo, G.; Boni, F.; Anzidei, M.; Catalano, C. // AIP Conference Proceedings;2017, Vol. 1821 Issue 1, p1 

    To assess safety and feasibility of non-invasive high intensity 3T MR guided focused ultrasound (MRgFUS) treatment of localized prostate cancer in an exploratory designed study. Men aged 45-80 years were eligible for this prospective study if they had low-risk localized prostate cancer (prostate...

  • Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro-Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer. Yusuke Inoue; Yuji Asano; Takefumi Satoh; Ken-ichi Tabata; Kei Kikuchi; Reiko Woodhams; Shiro Baba; Kazushige Hayakawa // Asia Oceania Journal of Nuclear Medicine & Biology;2014, Vol. 2 Issue 2, p87 

    Objective(s): We performed a phase IIa clinical trial of trans-1-amino-3-18F-fluoro-cyclobutane carboxylic acid (anti-18F-FACBC), a synthetic amino acid analog for PET, in patients with metastatic prostate cancer. Methods: The study subjects consisted of 10 untreated prostate cancer patients...

  • Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapy. Amanie, J.; Jans, H. S.; Wuest, M.; Pervez, N.; Murtha, A.; Usmani, N.; Yee, D.; Pearcey, R.; Danielson, B.; Patel, S.; Macewan, R.; Field, C.; Robinson, D.; Wilson, J.; Lewis, D.; Parliament, M.; McEwan, A. J. B. // Current Oncology;Apr2013, Vol. 20 Issue 2, p104 

    Purpose The objective of the present study was to analyze, with relatively high sensitivity and specificity, uptake properties of [11C]-choline in prostate cancer patients by means of positron-emission tomography (PET)/ computed tomography (CT) imaging using objectively defined pet parameters to...

  • C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel. Ceci, Francesco; Castellucci, Paolo; Graziani, Tiziano; Schiavina, Riccardo; Renzi, Riccardo; Borghesi, Marco; Tullio, Piergiorgio; Brunocilla, Eugenio; Ardizzoni, Andrea; Fanti, Stefano // European Journal of Nuclear Medicine & Molecular Imaging;Jan2016, Vol. 43 Issue 1, p84 

    Purpose: To investigate the role of C-choline PET/CT for evaluating the response to treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with docetaxel in comparison with PSA response. Methods: Inclusion criteria were (a) proven mCRPC, (b) docetaxel as first...

  • Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. Wei, Haibin; Shao, Yi; Sun, Feng; Sun, Xiaowen; Zhuo, Jian; Zhao, Fujun; Han, Bangmin; Jiang, Juntao; Chen, Huirong; Xia, Shujie // World Journal of Urology;Aug2014, Vol. 32 Issue 4, p1077 

    Purpose: To compare the safety and efficiency of thulium laser resection of the prostate-tangerine technique (TmLRP-TT) and plasmakinetic resection of the prostate (PKRP) for aged symptomatic benign prostatic hyperplasia (BPH) patients with large volume prostates (>80 ml) in a prospective...

  • C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. Ceci, Francesco; Castellucci, Paolo; Mamede, Marcelo; Schiavina, Riccardo; Rubello, Domenico; Fuccio, Chiara; Ambrosini, Valentina; Boschi, Stefano; Martorana, Giuseppe; Fanti, Stefano // European Journal of Nuclear Medicine & Molecular Imaging;Feb2013, Vol. 40 Issue 2, p149 

    Purpose: To determine the diagnostic efficacy of C-choline PET/CT in patients with prostate cancer (PC) after radical prostatectomy who presented with increasing PSA levels during follow-up in spite of being on hormone treatment (HT), and therefore showing HT resistance. Methods: We evaluated a...

  • Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature. Chung Yao Yu; Desai, Bhushan; Lingyun Ji; Groshen, Susan; Jadvar, Hossein // American Journal of Nuclear Medicine & Molecular Imaging;2014, Vol. 4 Issue 6, following p580 

    Positron emission tomography (PET) with a number of tracers targeted to particular biological features of cancer has been explored for the imaging evaluation of patients with biochemical recurrence of prostate cancer after curative primary treatment. However, these reports are often...

  • Treatment of advanced prostatic carcinoma.  // British Medical Journal;9/29/1979, Vol. 2 Issue 6193, p752 

    Focuses on the management of prostatic carcinoma. Conduction of transurethral resection for urinary outflow obstruction of the primary tumor; Employment of radiotherapy for pain from localised bone metastases; Affectivity of cyclophosphamide in advanced cases.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics